Featured research - TAVI - Part 13

Facilitators: W. K. Kim, T. Hovasse

Speakers: G. Tirado Conte, L. Asmarats Serra, F. Pensotti, W. H. Yin, I. Malik

Summary

This session delves into key clinical and procedural advances in TAVI, including the randomized PAF-TAVI trial assessing amiodarone for preventing post-TAVI atrial fibrillation, cost comparisons of balloon-expandable tissue preservation valves versus other devices, leaflet modification methods to reduce coronary obstruction risk, optimization techniques for valve-in-valve TAVI in small bioprostheses, and evidence supporting safe and effective day-case TAVI protocols based on UK data.

Presentations available when logged in:

Amiodarone for prevention of new-onset atrial fibrillation after TAVI: PAF-TAVI randomised trial
Cost comparison of balloon-expandable tissue preservation technology valve versus other TAVI valves
Leaflet modification for TAVI at high-risk of coronary obstruction: a minimalist approach
Optimising hemodynamics in valve-in-valve TAVI for small surgical bioprostheses
Day case TAVI: feasible, safe, and effective. UK data on over 300 cases and a consensus protocol

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Featured research - TAVI - Part 13

Log in or create account for free